Skip to main content

Table 1 Demographics of study participants

From: Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A

Trial registration number NCT00427830 NCT00456183 NCT00460590 NCT00480558
Country UK UK South Africa South Africa
No of participants 11 11 10 12
LTBI - + - +
History of BCG + +/− +/− +/−
Dose of MVA85A 5 × 107 PFU 5 × 107 PFU 5 × 107 PFU 5 × 107 PFU
Age, median (range) 27 (21–54) 30.5 (20–49) 35.5 (20.7–48.7) 36 (27–49)
Gender, % male 39 83 33.3 75
serum samples available, week (number) 0 (10), 1 (5), 4 (8) 0 (10), 1 (6), 4 (10) 0 (10), 1 (10) -
PBMC samples available, week (number) 0 (8), 1 (9), 4 (9) - - -